{"id":32318,"date":"2023-08-29T15:56:27","date_gmt":"2023-08-29T13:56:27","guid":{"rendered":"https:\/\/www.transgene.com\/?p=32318"},"modified":"2026-01-13T17:17:15","modified_gmt":"2026-01-13T16:17:15","slug":"phase-ib-ii-trial-of-tipapkinogene-sovacivec-tg4001-a-therapeutic-human-papillomavirus-16-vaccine-in-combination-with-avelumab-in-patients-with-advanced-human-papillomavirus-16-positive-cancers","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/phase-ib-ii-trial-of-tipapkinogene-sovacivec-tg4001-a-therapeutic-human-papillomavirus-16-vaccine-in-combination-with-avelumab-in-patients-with-advanced-human-papillomavirus-16-positive-cancers\/","title":{"rendered":"Phase Ib\/II trial of tipapkinogene sovacivec (TG4001), a therapeutic human papillomavirus 16-vaccine, in combination with avelumab in patients with advanced human papillomavirus 16-positive cancers"},"content":{"rendered":"\n<p class=\"eplus-DVrMbh\"> C. Le Tourneau, et al.<br\/>European Journal of Cancer, July 2023 (191)<br\/>T\u00e9l\u00e9charger l&rsquo; <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0959804923003337\"><strong>Article<\/strong><\/a><br\/><em>Publication<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>C. Le Tourneau, et al.European Journal of Cancer, July 2023 (191)T\u00e9l\u00e9charger l&rsquo; ArticlePublication<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[181,164,5,23,94],"tags":[],"class_list":["post-32318","post","type-post","status-publish","format-standard","hentry","category-other-fr","category-164","category-publication-fr","category-tg4001-fr","category-tg4001-ok","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"alcyon","author_link":"https:\/\/www.transgene.com\/fr\/author\/alcyon\/"},"uagb_comment_info":0,"uagb_excerpt":"C. Le Tourneau, et al.European Journal of Cancer, July 2023 (191)T\u00e9l\u00e9charger l&rsquo; ArticlePublication","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/32318","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=32318"}],"version-history":[{"count":4,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/32318\/revisions"}],"predecessor-version":[{"id":40470,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/32318\/revisions\/40470"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=32318"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=32318"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=32318"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}